Krishna Institute of Medical Sciences Ltd
Wed 21/05/2025,15:51:26 | NSE : KIMS
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 643.70
Previous Close
₹ 639.00
Volume
1104023
Mkt Cap ( Rs. Cr)
₹26519.21
High
₹ 666.50
Low
₹ 635.25
52 Week High
₹ 708.00
52 Week Low
₹ 350.00
Book Value Per Share
₹ 50.03
Dividend Yield
0.00
Face Value
₹ 2.00
What’s Your Call?
Collective community sentiment on Krishna Institute of Medical Sciences Ltd
Your Vote -
Buy
41.57%
Hold
33.71%
Sell
24.72%
41.57%
89 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
662.75
161
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
161
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Krishna Institute of Medical Sciences Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Krishna Institute - Analysts/Institutional Investor Meet/Con. Call Updates
-
Krishna Institute - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Krishna Institute - Copy of Newspaper Publication
-
Krishna Institute - Investor Presentation
-
Krishna Institute - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Krishna Institute - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Krishna Institute - Press Release
-
Krishna Institute - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Krishna Institute - Announcement under Regulation 30 (LODR)-Change in Management
-
Krishna Institute - Appointment
-
Krishna Institute - Announcement under Regulation 30 (LODR)-Change in Management
-
Krishna Institute - Re-Appointment Of Mrs. Y. Prameela Rani As An\r\nIndependent Director For The Further Period Of 5 Years W
-
Krishna Institute Q4 net profit jumps 94.02% at Rs 93.50 cr
-
Krishna Institute - General Updates
-
Krishna Institute - General Updates
-
Krishna Institute - Results-Financial Result For The Quarter And Year Ended 31.03.2025
-
Krishna Institute - Board Meeting Outcome for Outcome Of Board Meeting
-
Krishna Institute - Outcome of Board Meeting
-
Krishna Institute - Outcome of Board Meeting
-
Krishna Institute - Analysts/Institutional Investor Meet/Con. Call Updates
-
Krishna Institute - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Krishna Institute - Board Meeting Intimation for KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED Has Informed The Exchange Abou
-
Krishna Institute - Board Meeting Intimation
-
Krishna Institute - Other Restructuring-XBRL
-
Krishna Institute - General Updates
-
Krishna Institute - KIMS : Krishna Institute Of Medical Sciences Limited Has Informed Regarding Receipt Of Approval Under Reg
-
Krishna Institute has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Krishna Institute - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Krishna Institute - Trading Window-XBRL
-
Krishna Institute - Trading Window
-
Krishna Institute - Analysts/Institutional Investor Meet/Con. Call Updates
-
Krishna Institute - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Krishna Institute - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Krishna Institute - Analysts/Institutional Investor Meet/Con. Call Updates
-
Krishna Institute - Shareholders meeting
-
Krishna Institute - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
-
Krishna Institute - Analysts/Institutional Investor Meet/Con. Call Updates
-
Krishna Institute - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Krishna Institute - Analysts/Institutional Investor Meet/Con. Call Updates
-
Krishna Institute - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Krishna Institute - General Updates
-
Krishna Institute - Krishna Institute Of Medical Sciences Limited Has Informed The Exchange About Intimation Of The Order Rec
-
Krishna Institute - Analysts/Institutional Investor Meet/Con. Call Updates
-
Krishna Institute - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Krishna Institute enters into an operations & management agreement with Splendid Hospitals
-
KIMS Hospitals enters into a strategic partnership with UAIMS Hospital
-
Krishna Institute of Medical Science
-
KIMS signs MoU with Wipro GE Healthcare
-
Krishna Institute of Medical Science
-
Krishna Institute of Medical Sciences
Key fundamentals
Evaluate the intrinsic value of Krishna Institute of Medical Sciences Ltd stock
Name | March-25 | March-24 | March-23 | March-22 | March-21 |
---|---|---|---|---|---|
Assets | 2876 | 2192.742 | 1635.029 | 1395.956 | 1027.669 |
Liabilities | 2876 | 2192.742 | 1635.029 | 1395.956 | 1027.669 |
Equity | 80 | 80.028 | 80.028 | 80.028 | 77.593 |
Gross Profit | 416.5 | 364.407 | 360.283 | 396.22 | 304.029 |
Net Profit | 302.9 | 235.341 | 252.489 | 278.367 | 188.649 |
Cash From Operating Activities | 293.6 | 262.389 | 269.962 | 284.374 | 291.349 |
NPM(%) | 21.88 | 19.25 | 22.3 | 24.34 | 20.22 |
Revenue | 1384.1 | 1222.054 | 1132.023 | 1143.376 | 932.689 |
Expenses | 967.6 | 857.647 | 771.74 | 747.156 | 628.66 |
ROE(%) | 15.12 | 11.75 | 12.61 | 13.9 | 9.42 |
Corporate Action
XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
---|
Peers
Other companies within the same industry or sector that are comparable to Krishna Institute of Medical Sciences Ltd
Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
---|---|---|---|---|---|---|
Albert David Ltd | 810.15 | -0.84 | 26.88 | 364.58 | 301.39 | 0.62 |
Lotus Eye Hospital and Institute Ltd | 74.06 | 0.78 | 308.58 | 1328.47 | 14.01 | 0.68 |
Vaishali Pharma Ltd | 12.85 | -1.15 | 428.33 | 684.74 | 2.76 | 0.00 |
Astec Lifesciences Ltd | 701.25 | -1.59 | 0.00 | 1252.63 | -687.11 | 0.00 |
Company Info
The Company was incorporated as `Jagjit Singh and Sons Private Limited', a private limited company under the Companies Act, 1956, with a certificate of incorporation issued by the Registrar of Companies, Maharashtra on July 26, 1973 at Mumbai. the Company changed the location of its registered office from the State of Maharashtra to the erstwhile State of Andhra Pradesh, pursuant to an order dated January 29, 2003 by the Company Law Board, Western Region Bench, Mumbai ("Order") and the registration of the Order vide certificate of registration dated February 21, 2003 by the RoC (then the Assistant Registrar of Companies, Andhra Pradesh). Subsequently, the name of the Company was changed to `Krishna Institute of Medical Sciences Private Limited', pursuant to a letter of approval from the GoI dated January 2, 2004 and a fresh certificate of incorporation issued by the RoC on January 2, 2004. Pursuant to the conversion of the Company to a public limited company, the name was changed to `Krishna Institute of Medical Sciences Limited' and the RoC issued a fresh certificate of incorporation on January 29, 2004. Until the year 2003, the Company was owned, managed and controlled by Jagjit Singh and certain of his family members, who together owned the entire shareholding of the Company. On February 15, 2003, acting in pursuance of the Takeover MoU, certain of the Promoters, namely Dr. Bhaskara Rao Bollineni and BRMH, along with certain other individuals and entities, acquired the entire equity share capital of the Company (then `Jagjit Singh and Sons Private Limited'). We have not been able to trace the complete set of documents pertaining to corporate, accounting, financial, legal and other statutory records, including any supporting documents and/or RoC filings for the period prior to the Takeover MoU. Therefore, we are unable to conclusively ascertain, amongst others, all amendments to the Memorandum of Association of the Company until February 2003.Major events and milestones of the Company :2000- KIMS Nellore established by BRMH. The business division of BRMH, including the hospital, was transferred to the Company pursuant to the 2012 Scheme.2004- KIMS Secunderabad established by the Company2010- Investment by Milestone Private Equity Fund ("MPEF") in the Company2014- KIMS Kondapur established by KHEPL, the Subsidiary*- Acquisition of 57.83% of the equity shareholding of Arunodaya Hospitals Private Limited2015- Investment by India Advantage Fund ("IAF") and Emerging India Fund ("EIF") and exit of MPEF from the Company pursuant to the share purchase agreement dated June 23, 2014 entered into between, amongst others, IAF, EIF and MPEF2017- Acquisition of KIMS Ongole by way of slump sale agreement2019- Acquisition of 51% of the equity shareholding of ICIMSPL- Acquisition of 80% of the equity shareholding of SIMSPL- Investment by General Atlantic in the Company and exit of IAF and EIF from the Company pursuant to the share purchase agreement dated June 14, 2018 entered into between, amongst others, General Atlantic, IAF and EIF2020-Acquisition of 55% of the equity shareholding of KHKPL 2022 -Krishna Institute of Medical Sciences Acquisition of 51% stake in Spanv Medisearch Lifesciences Private Limited (Kingsway Hospitals). 2023 -KIMS Hospitals, Secunderabad ranked the Second Best Multispeciality Hospital in Hyderabad by The Week Magazine. -KIMS-Kingsway Hospitals ranked the Fourth Best Multispeciality Private Hospital in Nagpur by The Week Magazine. -KIMS-Sunshine Hospitals ranked the Sixth Best Multispeciality Hospital in Hyderabad by The Week Magazine. 2024 -The Company has splits its face value from Rs. 10/- to Rs. 2/-. -The Company Informed about Acquisition of further equity stake in Sarvejana Healthcare Private Limited. -The Company has acquired 100% stake in Queen's NRI Hospital, Vizag. -The Company has informed the Exchange regarding 'Acquisition of land on a 99-year lease and purchase of building for the setting up of a new Hospital at Thane'.
The Company was incorporated as `Jagjit Singh and Sons Private Limited', a private limited company under the Companies Act, 1956, with a certificate of incorporation issued by the Registrar of Companies, Maharashtra on July 26, 1973 at Mumbai. the Company changed the location of its registered office from the State of Maharashtra to the erstwhile State of Andhra Pradesh, pursuant to an order dated January 29, 2003 by the Company Law Board, Western Region Bench, Mumbai ("Order") and the registration of the Order vide certificate of registration dated February 21, 2003 by the RoC (then the Assistant Registrar of Companies, Andhra Pradesh). Subsequently, the name of the Company was changed to `Krishna Institute of Medical Sciences Private Limited', pursuant to a letter of approval from the GoI dated January 2, 2004 and a fresh certificate of incorporation issued by the RoC on January 2, 2004. Pursuant to the conversion of the Company to a public limited company, the name was changed to `Krishna Institute of Medical Sciences Limited' and the RoC issued a fresh certificate of incorporation on January 29, 2004. Until the year 2003, the Company was owned, managed and controlled by Jagjit Singh and certain of his family members, who together owned the entire shareholding of the Company. On February 15, 2003, acting in pursuance of the Takeover MoU, certain of the Promoters, namely Dr. Bhaskara Rao Bollineni and BRMH, along with certain other individuals and entities, acquired the entire equity share capital of the Company (then `Jagjit Singh and Sons Private Limited'). We have not been able to trace the complete set of documents pertaining to corporate, accounting, financial, legal and other statutory records, including any supporting documents and/or RoC filings for the period prior to the Takeover MoU. Therefore, we are unable to conclusively ascertain, amongst others, all amendments to the Memorandum of Association of the Company until February 2003.Major events and milestones of the Company :2000- KIMS Nellore established by BRMH. The business division of BRMH, including the hospital, was transferred to the Company pursuant to the 2012 Scheme.2004- KIMS Secunderabad established by the Company2010- Investment by Milestone Private Equity Fund ("MPEF") in the Company2014- KIMS Kondapur established by KHEPL, the Subsidiary*- Acquisition of 57.83% of the equity shareholding of Arunodaya Hospitals Private Limited2015- Investment by India Advantage Fund ("IAF") and Emerging India Fund ("EIF") and exit of MPEF from the Company pursuant to the share purchase agreement dated June 23, 2014 entered into between, amongst others, IAF, EIF and MPEF2017- Acquisition of KIMS Ongole by way of slump sale agreement2019- Acquisition of 51% of the equity shareholding of ICIMSPL- Acquisition of 80% of the equity shareholding of SIMSPL- Investment by General Atlantic in the Company and exit of IAF and EIF from the Company pursuant to the share purchase agreement dated June 14, 2018 entered into between, amongst others, General Atlantic, IAF and EIF2020-Acquisition of 55% of the equity shareholding of KHKPL 2022 -Krishna Institute of Medical Sciences Acquisition of 51% stake in Spanv Medisearch Lifesciences Private Limited (Kingsway Hospitals). 2023 -KIMS Hospitals, Secunderabad ranked the Second Best Multispeciality Hospital in Hyderabad by The Week Magazine. -KIMS-Kingsway Hospitals ranked the Fourth Best Multispeciality Private Hospital in Nagpur by The Week Magazine. -KIMS-Sunshine Hospitals ranked the Sixth Best Multispeciality Hospital in Hyderabad by The Week Magazine. 2024 -The Company has splits its face value from Rs. 10/- to Rs. 2/-. -The Company Informed about Acquisition of further equity stake in Sarvejana Healthcare Private Limited. -The Company has acquired 100% stake in Queen's NRI Hospital, Vizag. -The Company has informed the Exchange regarding 'Acquisition of land on a 99-year lease and purchase of building for the setting up of a new Hospital at Thane'.
Read More
Parent Organisation
Krishna Institute of Medical Sciences Ltd.
Founded
26/07/1973
Managing Director
Dr.Abhinay Bollineni
NSE Symbol
KIMSEQ
FAQ
The current price of Krishna Institute of Medical Sciences Ltd is ₹ 662.75.
The 52-week high for Krishna Institute of Medical Sciences Ltd is ₹ 666.50 and the 52-week low is ₹ 635.25.
The market capitalization of Krishna Institute of Medical Sciences Ltd is currently ₹ 26519.21. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Krishna Institute of Medical Sciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Krishna Institute of Medical Sciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Krishna Institute of Medical Sciences Ltd shares.
The CEO of Krishna Institute of Medical Sciences Ltd is Dr.Abhinay Bollineni, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.